🚀 Zacks Small Cap Research - LEXX: Introducing DehydraTECH 3.0
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-lexx-introducing-dehydratech-3-0/
#LexariaBi#LexariaBiosciencec#LEXX #ZacksSCRE#DehydraTECHr#DHT30v#OralDeliveryt#GLP1i#retatrutiden#amycretind#SNACp#sodiumcapr

🚀 Zacks Small Cap Research - LEXX: Dosing Started for Animal & Human GLP-1 Studies
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-lexx-dosing-started-for-animal-human-glp-1-studies/
#LexariaBi#LexariaBioscienceP#LEXXP#GLP1i#GLP1AgonistE#DehydraTECHC#DHTD#SNACt#CBDref="/hashtag/Biot" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#Biot

Lexaria Bioscience CEO Richard Christopher summarizes details from $LEXX human clinical trials evaluating #DehydraTECH & GLP1 agonists along with the technology’s key benefits.
#LexariaBioscience #LexariaDelivery #NextGenDrugDelivery #OralDeliveryTech #OralPeptideDelivery #GLP1Therapy #GLP1Agonist

🚀 Zacks Small Cap Research - LEXX: Animal & Human GLP-1 Studies Continue
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-lexx-animal-human-glp-1-studies-continue/
#LexariaBi#LexariaBioscienceP#LEXXP#GLP1i#GLP1AgonistsE#DehydraTECHa#DHTi#SemaglutideS#Wegovya#SNACa href="/hashtag/PharmaR" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#PharmaR

#$LEXX
The GLP-1 category has been defined by the molecules. The next round of value is being built one layer down, in the delivery technology that determines how those molecules reach the patient.Lexaria is building an alternative.
#GLP1 #LEXX #LexariaBioscience